1. Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice. (November 2016) Authors: Chamorro-de-Vega, Esther; Gimenez-Manzorro, Alvaro; Rodriguez-Gonzalez, Carmen Guadalupe; Escudero-Vilaplana, Vicente; Collado Borrell, Roberto; Ibañez-Garcia, Sara; Lallana Sainz, Elena; Lobato Matilla, Elena; Lorenzo-Pinto, Ana; Manrique-Rodriguez, Silvia; Fernandez-Llamazares, Cecilia M.; Marz... Journal: Annals of pharmacotherapy Issue: Volume 50:Number 11(2016:Nov.) Page Start: 901 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗